Certoparin sodium

舍托肝素钠

Report date: 2025/07/18 17:32:44
NME

Base Information

Drug NameCertoparin sodium
Drug Alias NameCertoparinTroparinAlphaparinSandoparinSandoparine +[6] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIIProthrombinCoagulation factor X
Therapy Area/IndicationsVenous ThrombosisThromboembolismEmbolism +[7] 
Global Approved IndicationsVenous ThrombosisThromboembolismPulmonary Embolism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1997/01/01
Country/TerritoryUnited StatesHungaryAustria +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesAspen Pharma
Inactive CompaniesNovartis Pharma Ag
Active IndicationsVenous ThrombosisThromboembolismPulmonary Embolism
Inactive IndicationsEmbolismAtrial FibrillationRenal Insufficiency +[4] 

Other Information

ATC CodeB01AB
Related LinksWikipediaDrugBank